Perspectively, understanding the precise molecular mechanism underlying 14.7K-mediated apoptosis blockade could be exploited as a therapeutic strategy for treatment of disorders associated with increased TNF-levels such as rheumatoid arthritis and Crohn’s disease. This evidence concerns the gene TNF and rheumatoid arthritis.